Sexual Risks in Prep Users

Analysis of Sexual Risks in Prep (Pre-exposure Prophylaxis) Users Followed-up in a University Care Centre (Le Trait d'Union)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03975517

Acronym

PREP

Enrollment

200

Registered

2019-06-05

Start date

2019-06-04

Completion date

2020-03-05

Last updated

2022-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infection, Prep Prescription, Sexually Transmitted Diseases, Vaccinations

Keywords

Prep, Sexual behavior, HIV, Syphilis, Chlamydia infection, Hepatitis, Gonococcus

Brief summary

Primary purpose of the study: to describe sexual behavior of Prep users, whatever mode of intake, ie continuous or on-demand; it has been shown in some studies, an increase of sexual risks in Prep users, and therefore an similar increase of STIs (sexually transmitted diseases); using a self-questionnaire, we'd like to evaluate sexual behavior before, and 6 months after, starting Prep. Secondary purposes: to describe medical characteristics of Prep users (past medical condition, demographic characteristics, vaccinations, kidney function, serological results, urine and anal/pharyngeal swabs), clinical and biological Prep safety, STIs occurrence, and antibiotic prescriptions, continuous or on-demand intake, Prep indication.

Interventions

BEHAVIORALPrEP

Define the behavioral characteristics of the active file of patients using PrEP in Strasbourg in 2019.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* non HIV-infected subjects * men aged 18 years or older * having non protected sexual relationship * taking Prep (emtricitable/tenofovir disoproxil fumarate) either every day, or on-demand * affiliated to social security

Exclusion criteria

* HIV-infected patients * refusal of study participation * not on Prep * not fluent in French language * safeguarding justice * on guardianship or trusteeship

Design outcomes

Primary

Measure	Time frame	Description
Analysis of sexual behavior in Prep users	6 months	Sexual behavior will be evaluated with a questionnaire

Secondary

Measure	Time frame	Description
Description of the medical profile of the Strasbourgeoise active file	6 months	Describe the active line of people using Prep and followed in the center

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026